E-LIB Suche - Ergebnisse für: Lebrec, Jeremie

1

The real-world observational prospective study of health ou..:

Barrett, Annabel ; Boye, Kristina S. ; García-Pérez, Luis-Emilio...
Journal of Medical Economics. 27 (2024) 1 - p. 866-879 , 2024

Link: https://doi.org/10.1080/..

2

The Real‐World Observational Prospective Study of Health Ou..:

Boye, Kristina S. ; Lebrec, Jérémie ; Dib, Anne...
Diabetes, Obesity and Metabolism. 25 (2023) 12 - p. 3453-3464 , 2023

Link: https://doi.org/10.1111/..

3

Clinical characteristics, treatment patterns, and persisten..:

Jung, Heike ; Tittel, Sascha R. ; Schloot, Nanette C....
Diabetes, Obesity and Metabolism. 25 (2023) 7 - p. 1813-1822 , 2023

Link: https://doi.org/10.1111/..

4

The real‐world observational prospective study of health ou..:

Giorgino, Francesco ; Guerci, Bruno ; Füchtenbusch, Martin...
Diabetes, Obesity and Metabolism. 25 (2023) 12 - p. 3465-3477 , 2023

Link: https://doi.org/10.1111/..

5

Age‐dependent prevalence of type 2 diabetes, cardiovascular..:

Otto, Thorsten ; Diesing, Joanna ; Borchert, Julia...
Diabetes, Obesity and Metabolism. 25 (2022) 3 - p. 767-775 , 2022

Link: https://doi.org/10.1111/..

6

TheReal‐WorldObservational Prospective Study of Health Outc..:

Guerci, Bruno ; Giorgino, Francesco ; Sapin, Hélène...
Diabetes, Obesity and Metabolism. 24 (2022) 12 - p. 2373-2382 , 2022

Link: https://doi.org/10.1111/..

7

Real-World Use of Insulin Glargine U100 and U300 in Insulin..:

Duque, Natalia ; Artime, Esther ; Romera, Irene...
Advances in Therapy. 38 (2021) 7 - p. 3857-3871 , 2021

Link: https://doi.org/10.1007/..

8

Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabete..:

Norrbacka, Kirsi ; Sicras-Mainar, Antoni ; Lebrec, Jeremie...
Diabetes Therapy. 12 (2021) 5 - p. 1535-1551 , 2021

Link: https://doi.org/10.1007/..

9

Treatment Patterns and Persistence With GLP-1 RA Treatments..:

Zimner Rapuch, Sarah ; Divino, Victoria ; Norrbacka, Kirsi...
Diabetes Therapy. 12 (2021) 5 - p. 1553-1567 , 2021

Link: https://doi.org/10.1007/..

10

Treatment persistence in patients with type 2 diabetes trea..:

Svensson, Ann‐Marie ; Toll, Anders ; Lebrec, Jeremie...
Diabetes, Obesity and Metabolism. 23 (2020) 3 - p. 720-729 , 2020

Link: https://doi.org/10.1111/..

11

Once-weekly dulaglutide versus insulin glargine in the earl..:

Romera, Irene ; Conget, Ignacio ; Vazquez, Luis Alberto...
Journal of Diabetes and its Complications. 34 (2020) 7 - p. 107575 , 2020

Link: https://doi.org/10.1016/..

12

The Cost of Hypoglycemia Associated With Type 2 Diabetes Me..:

Strizek, Alena ; Chang, Chee-Jen ; Furnback, Wesley...
Value in Health Regional Issues. 18 (2019) - p. 84-90 , 2019

Link: https://doi.org/10.1016/..

13

Dulaglutide treatment results in effective glycaemic contro..:

Pozzilli, Paolo ; Leslie, Richard D. ; Peters, Anne L....
Diabetes, Obesity and Metabolism. 20 (2018) 6 - p. 1490-1498 , 2018

Link: https://doi.org/10.1111/..

14

Potential cost savings to be made by slowing cognitive decl..:

Lenox-Smith, Alan ; Reed, Catherine ; Lebrec, Jeremie..
BMC Geriatrics. 18 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

15

Utilization Patterns of Glucagon-Like Peptide-1 Receptor Ag..:

Federici, Marco Orsini ; McQuillan, Janette ; Biricolti, Giovanni...
Diabetes Therapy. 9 (2018) 2 - p. 789-801 , 2018

Link: https://doi.org/10.1007/..